Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIRS Steroids In Cardiac Surgery Trial
2011-001099-21Phase 4Completed
- Sponsor
- Population Health Research Institute
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cardiac morbidity, Myocardial injury and Systemic Inflammatory Response Syndrome (SIRS) comparing Methylprednisolone arm with Placebo / standard care arm (2 arms). Primary endpoint: 30-day all-cause mortality. Started Apr 2011; status: completed.
02
Drugs
methylprednisolone
03
Conditions
cardiac morbidityMyocardial injurySystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on 2011-001099-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001099-21.